High materiality9/10
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $29 at Canaccord
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord raises ZVRA PT to $29; current price about $12.09; substantial upside potential.
- PT $29; price $12.09; upside ~140%.
Key facts
- 01
Target: $29
- 02
Posted price: $12.09
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Sumant Kulkarni
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.